F.No. 8(35)/2001-DP/NPPA-Div.-II

National Pharmaceutical Pricing Authority
Ministry of Chemicals & Fertilizers
Government of India

2E/21, Jhandewalan Extn.,
New Delhi-110 055

Dated : 2nd July, 2001

Explanatory Note

The National Pharmaceutical Pricing Authority has revised/fixed the prices of 77 formulation packs on June 29, 2001. The prices have been fixed for the first time in the case of 8 formulation packs. In the case of 69 packs the prices have been revised downward, ranging from 0.29% to 84.83%.  The revision in prices was warranted due to downward revision in the prices of Scheduled bulk drugs namely Ibuprofen, Famotidine, Nalidixic Acid, Dexamethasone Sodium Phosphate, Haematinic Iron Combination, Multi Vitamins.  Out of these 77 packs, the prices of 70 packs were revised on suo-motu basis as per the provisions of the DPCO, 1995 as the manufacturers, though required to apply for price revision, did not do so.

Of the 77 formulation packs, ceiling prices (exclusive of excise duty and local taxes etc.) have been fixed in respect of 73 packs. The non-ceiling prices (inclusive of excise duty but exclusive of local taxes etc.) have been fixed in respect of the remaining 4 packs.  The prices have been fixed/revised in accordance with the provisions of the DPCO, 1995 and as per the established criteria and guidelines. A copy of the statement showing the existing (where available) and revised prices is enclosed herewith.  The information are also available at NPPA’s website www.nppaindia.com.

The formulations for which prices have been revised/fixed are Haematinic Iron combination used in the defficiency of Iron, Ibuprofen+Chlorozoxazone Tablet used as a pain reliever, Furazolidone+Loperamide used in the treatment of diarrhoea, Dexamethasone Sodium Phosphate used as anti inflammatory, Aspirin used in the treatment of Cardiovascular diseases.  Famotidine used in the cure of peptic ulcer, Nalidixic Acid based formulations used as anti diarrhoea, Tolnaftate used in the treatment of Fungal desease, and Multi-Vitamins preparations in oral, liquids and injection forms.

The prices fixed/revised would become effective within 15 days from the date of notification in the official gazette or the receipt of the order of the NPPA in this behalf, as per Para 14(1) of DPCO, 1995.  Necessary revised price list is to be issued by the manufacturers/importers required under sub paragraph (3) of paragraph 14 of the DPCO, 1995.  Accordingly, as per the provisions of the DPCO, the revised price list in Form-V is to be furnished by the concerned manufacturer(s) to the government/NPPA, State Drug Control Authorities and distributors, wholesalers and retailers, etc.

The manufacturers are also required to work out the pro-rata prices of different pack sizes as the case may be in terms of S.O. No. 83 (E) dated 27.01.98.

(L. M. KAUSHAL)
Dy. Director